Pathfinder Cell Therapy, Inc. (PFND) Research

Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.

Market snapshot

Symbol
PFND
Price
$0.00
Day change
0.00%
Market cap
$66.7K
P/E ratio
-0.04x
52-week range
0.000001-0.0001
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Biotron Limited (BITRF)
  • Bangi Inc. (BNGI)
  • Biophytis S.A. (BPTSY)
  • THC Farmaceuticals, Inc. (CBDG)
  • Innovation Pharmaceuticals Inc. (IPIX)
  • MultiCell Technologies, Inc. (MCET)
  • Regen BioPharma, Inc. (RGBP)
  • RespireRx Pharmaceuticals Inc. (RSPI)

Open Pathfinder Cell Therapy, Inc. (PFND) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.